Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...

Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...

Meteorological factors accounted for less than 1% of the variation in patient-reported outcomes among individuals with psoriatic arthritis. Meteorological factors may account for less than 1% of the ...

Sicca is not a feature of RA. Psoriatic arthritis (PSA) is a type of arthritis linked to the autoimmune skin condition ...

If you have eczema you’ll be all too familiar with those cracked, dry, and scaly patches of skin that show up a bright red on ...

Study authors examined the use of artificial intelligence in machine learning models for the assessment of psoriasis severity, as well as identified future research needs.

Microbial diversity in the gut of people with rheumatoid arthritis is significantly reduced compared to that of the healthy individual, a new study shows.

Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term marketable ...

Medically reviewed by Casey Gallagher, MD Psoriasis of the hands and feet, known as palmoplantar psoriasis, is an inflammatory autoimmune disorder that causes scaly, itchy skin patches on the palms ...